Trade GlaxoSmithKline PLC - GSKl CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.065 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023264% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001346% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | GBP | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United Kingdom of Great Britain and Northern Ireland | ||||||||
| Commission on trade | 0% |
| Prev. Close | 14.56 |
| Open | 14.58 |
| 1-Year Change | -14.18% |
| Day's Range | 14.45 - 14.745 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| May 2, 2025 | 14.450 | -0.005 | -0.03% | 14.455 | 14.765 | 14.450 |
| May 1, 2025 | 14.560 | -0.135 | -0.92% | 14.695 | 14.765 | 14.405 |
| Apr 30, 2025 | 14.735 | 0.435 | 3.04% | 14.300 | 15.030 | 14.125 |
| Apr 29, 2025 | 14.320 | 0.075 | 0.53% | 14.245 | 14.335 | 13.995 |
| Apr 28, 2025 | 14.080 | 0.210 | 1.51% | 13.870 | 14.115 | 13.870 |
| Apr 25, 2025 | 13.630 | -0.220 | -1.59% | 13.850 | 13.955 | 13.630 |
| Apr 24, 2025 | 13.895 | -0.015 | -0.11% | 13.910 | 13.915 | 13.615 |
| Apr 23, 2025 | 13.795 | 0.180 | 1.32% | 13.615 | 13.870 | 13.540 |
| Apr 22, 2025 | 13.600 | 0.110 | 0.82% | 13.490 | 13.610 | 13.245 |
| Apr 17, 2025 | 13.345 | 0.090 | 0.68% | 13.255 | 13.360 | 13.095 |
| Apr 16, 2025 | 13.420 | 0.330 | 2.52% | 13.090 | 13.500 | 13.090 |
| Apr 15, 2025 | 13.455 | 0.200 | 1.51% | 13.255 | 13.525 | 13.035 |
| Apr 14, 2025 | 12.915 | -0.050 | -0.39% | 12.965 | 13.260 | 12.915 |
| Apr 11, 2025 | 12.920 | 0.140 | 1.10% | 12.780 | 12.975 | 12.540 |
| Apr 10, 2025 | 12.735 | -0.495 | -3.74% | 13.230 | 13.335 | 12.695 |
| Apr 9, 2025 | 12.595 | -0.360 | -2.78% | 12.955 | 13.070 | 12.405 |
| Apr 8, 2025 | 13.110 | -0.245 | -1.83% | 13.355 | 13.595 | 13.025 |
| Apr 7, 2025 | 13.290 | -0.460 | -3.35% | 13.750 | 13.765 | 13.190 |
| Apr 4, 2025 | 14.145 | -0.420 | -2.88% | 14.565 | 14.670 | 14.060 |
| Apr 3, 2025 | 14.580 | 0.160 | 1.11% | 14.420 | 14.840 | 14.415 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
GSK Company profile
GlaxoSmithKline PLC - GSK CFD
GlaxoSmithKline (GSK) is a global healthcare company focussed in pharmaceuticals, vaccine development and consumer healthcare products.
The company began as an apothecary shop in London in 1715. Today, GlaxoSmithKline is headquartered in Brentford, England, with regional offices in the US and Singapore. GlaxoSmithKline’s primary listing is on the London Stock Exchange under the ticker symbol ‘GSK’. The GSK stock price in the form of American depositary shares is listed on the New York Stock Exchange.
GlaxoSmithKline’s pharmaceutical business covers a broad portfolio of medicines in respiratory, HIV, immuno-inflammation and oncology. The company has a leadership position in respiratory disease medicines. GlaxoSmithKline’s HIV business is managed through its unit ViiV Healthcare, with Pfizer and Shionogi as minority shareholders.
In addition to respiratory and HIV treatments, the company has a portfolio of pharmaceutical products for the treatment of conditions such as lupus, urology and anti-infectives.
Its Established Products Portfolio (EPP) includes mature medicines in the areas of anti-infectives, allergy, central nervous system, dermatology, respiratory and urology. These products are an important part of our Emerging Markets business.
GlaxoSmithKline is actively researching the World Health Organisation’s three priority diseases - HIV/AIDS, tuberculosis and malaria.
GlaxoSmithKline is also one of the world’s largest vaccine companies with a portfolio of more than 20 vaccines. The company has 12 vaccine manufacturing sites around the world. One of its four global R&D centres is dedicated to mRNA technology.
GlaxoSmithKline’s consumer healthcare business has portfolio of brands that include Sensodyne, Parodontax, Polident, Advil, Voltaire, Panadol, Striven, Theraflu and Centrum across oral health, pain relief, cold, flu and allergy, digestive health, and vitamins, mineral and supplements segments. GlaxoSmithKline is set to spin-off its consumer healthcare business into an independent company under the name ‘Haleon’.’
The company pays dividends on a quarterly basis, in July, October, January and April.
Follow the GlaxoSmithKline stock price live at Capital.com today.
| Industry: | Pharmaceuticals (NEC) |
980 Great West Road
BRENTFORD
MIDDLESEX TW8 9GS
GB
News
GME shares price forecast: Third-party price target
Read our GameStop (GME) share price forecast for 2025 and beyond, with insights from third-party analysts and market experts
11:40, 28 April 2025
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com